Member Info for Guiness25

“PETROFAC EXTENDS FORBEARANCE AGREEMENT WITH AD HOC GROUP OF NOTEHOLDERS

Petrofac has extended its existing forbearance agreement in respect of the non-payment of the interest coupon on its senior secured notes from 30 June to 25 July 2024.”

Sure you can all divert the main thread to a typo, but seriously, how much cash is actually left currently?

?

Possibly.

Hello Mary, havent crossed paths in a while. July should be the month things are sorted here in terms of liquiidity in my opinion. After all these months of waiting, I just can't see anything other than dilution coming or a buyout. If the latter, you'll obviously be quids in. Dilution more likely, IMO. Has to be very soon IMO.

A good, balanced summary JHfH, can't say fairer than that.

Https://x.com/gavinfi79738737/status/1805576042523885707

Seems HEMO are now ADVERTISING for funding. Despite many conferences Vlad has attended, hundreded of industry professionals and investors, he's advertising. Have to ask yourself why? Will HEMO eventually run our of money?

Isnt't it time that the previous, regular posters such as HfH and Hedge come back to this board to give their views on where HEMO is at currently, and have a proper discussion? Their lack of presence just adds weight to the fact they're grifters

This stock has to be bottoming, but the lack of cash must be now a HUGE worry for the board regarding what the company can do to progress. At the current rate it will reach ATL's - which is £0.0095, in April 2020.

And before anyone says it rocketed to 14p thereafter, that was COVID time!

DHUB - surely you know why this is slipping? It's for the reasons that have been discussed ever since the placing, and more recently, Vlad openly, in an RNS, explaining they need funding. Market sees a company with very few options, other than placing or going private, if non-diluting finance is not an option.

That is not me deramping beacause I want to get in. That is just fact. For me, HEMO is currently not investable given the extreme high risk it presents potential shareholders.

Quite obviously, if they receive non-diluting finance, or indeed, strike a deal of some kind for a JV, then the SP rockets. And if that happens, well done to all holders or new shareholders that have been willing to take the risk.

Risk too high, hence the SP continual decline.

Vlad is running out of financing options. In not so many words he has said that today. If no non-dilutive financing can be found, he will struggle to raise at all, let alone at 1p. What a spot to be in with so much going for the company from a science perspective.

All time lows will be hear soon enough if Vlad doesnt get off the Vodka and sorts out a plan for licensing.

Disgrace these 2 are.

Condemning people who were allegedly deramping, whilst all the time they were ramping. Where are they now? Nowhere to be seen.

And hedgbackwards even started that rubbish about going to the FCA - couldnt make it up.

How farcical.

Almost mid June, no news from Vlad. I believe he simply has not got the funds to complete Ph 1 - he may be able to start but not finish.

Increasingly, by his own admission, hard to raise in the current climate.

What is the company going to do? Unless im wrong, I believe the board is stuck and struggling to find a way forward.

Another raise will be 30% from current SP, meaning, if he raised soon, it will be around 1p. Of course he may have an institution interested, but that's probably wishful thinking. Or, he could sell the science as it currently stands. Or, they may have a breakthrough with CBR, but historics point to CBR being a raise catalyst.

Tricky.

Expect a couple very soon I'd say.

Checking in on HEMO is rather depressing - JFH and Hedge don't post anymore. Who were the real scammers? Makes you wonder

This company will not go bust. IMO. Too much future ahead. Buyout likely, dilution probable. I think a deal is done, this week for news?

Yawn.....

Why some believe trading commentary on forums is of interest staggers me, never understood it.

So what? Makes no difference, it's traded exactly the same as most AIM companies. Great news release, people dump, placing. End of.

Is Vlad finally out of options? How can he possibly progress without further funding and where is that coming from?

And where are the old faithfuls? Hedge. JHFH. The usual lot.

Is Vlad to pharma what George Roach is to lithium?